Annual Cash & Cash Equivalents
N/A
December 1, 2024
Summary
- MRK annual cash & cash equivalents is not available.
Performance
MRK Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
N/A
December 1, 2024
Summary
- MRK quarterly cash and cash equivalents is not available.
Performance
MRK Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
MRK Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
MRK Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time |
Merck & Co Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $14.59 B(+29.1%) |
| Jun 2024 | - | $11.30 B(+102.6%) |
| Mar 2024 | - | $5.58 B(-18.4%) |
| Dec 2023 | $6.84 B(-46.1%) | $6.84 B(-20.5%) |
| Sep 2023 | - | $8.61 B(+52.0%) |
| Jun 2023 | - | $5.66 B(-41.7%) |
| Mar 2023 | - | $9.71 B(-23.5%) |
| Dec 2022 | $12.69 B(+56.8%) | $12.69 B(+13.9%) |
| Sep 2022 | - | $11.14 B(+15.2%) |
| Jun 2022 | - | $9.68 B(+13.1%) |
| Mar 2022 | - | $8.56 B(+5.7%) |
| Dec 2021 | $8.10 B(+0.6%) | $8.10 B(-19.2%) |
| Sep 2021 | - | $10.02 B(+16.8%) |
| Jun 2021 | - | $8.57 B(+22.8%) |
| Mar 2021 | - | $6.98 B(-13.3%) |
| Dec 2020 | $8.05 B(-16.8%) | $8.05 B(+9.4%) |
| Sep 2020 | - | $7.36 B(-33.7%) |
| Jun 2020 | - | $11.10 B(+49.5%) |
| Mar 2020 | - | $7.42 B(-23.3%) |
| Dec 2019 | $9.68 B(+21.5%) | $9.68 B(+23.0%) |
| Sep 2019 | - | $7.87 B(+18.2%) |
| Jun 2019 | - | $6.66 B(-17.5%) |
| Mar 2019 | - | $8.08 B(+1.4%) |
| Dec 2018 | $7.96 B(+30.7%) | $7.96 B(+1.8%) |
| Sep 2018 | - | $7.83 B(+47.4%) |
| Jun 2018 | - | $5.31 B(+18.4%) |
| Mar 2018 | - | $4.48 B(-26.4%) |
| Dec 2017 | $6.09 B(-6.5%) | $6.09 B(-22.9%) |
| Sep 2017 | - | $7.90 B(+1.5%) |
| Jun 2017 | - | $7.79 B(-33.5%) |
| Mar 2017 | - | $11.71 B(+79.7%) |
| Dec 2016 | $6.51 B(-23.6%) | $6.51 B(-17.6%) |
| Sep 2016 | - | $7.91 B(+19.7%) |
| Jun 2016 | - | $6.61 B(-32.0%) |
| Mar 2016 | - | $9.72 B(+14.0%) |
| Dec 2015 | $8.52 B(+14.6%) | $8.52 B(+12.9%) |
| Sep 2015 | - | $7.55 B(+9.0%) |
| Jun 2015 | - | $6.92 B(-13.3%) |
| Mar 2015 | - | $7.98 B(+7.2%) |
| Dec 2014 | $7.44 B(-52.4%) | $7.44 B(-34.6%) |
| Sep 2014 | - | $11.37 B(+16.7%) |
| Jun 2014 | - | $9.74 B(-38.4%) |
| Mar 2014 | - | $15.83 B(+1.3%) |
| Dec 2013 | $15.62 B(+16.1%) | $15.62 B(+10.9%) |
| Sep 2013 | - | $14.09 B(-6.6%) |
| Jun 2013 | - | $15.09 B(+15.9%) |
| Mar 2013 | - | $13.02 B(-3.2%) |
| Dec 2012 | $13.45 B(-0.6%) | $13.45 B(-22.5%) |
| Sep 2012 | - | $17.36 B(+3.6%) |
| Jun 2012 | - | $16.75 B(+14.3%) |
| Mar 2012 | - | $14.66 B(+8.3%) |
| Dec 2011 | $13.53 B(+24.1%) | $13.53 B(-5.1%) |
| Sep 2011 | - | $14.25 B(+15.5%) |
| Jun 2011 | - | $12.34 B(+5.5%) |
| Mar 2011 | - | $11.70 B(+7.3%) |
| Dec 2010 | $10.90 B(+17.1%) | $10.90 B(+25.8%) |
| Jun 2010 | - | $8.67 B(+5.2%) |
| Mar 2010 | - | $8.24 B(-11.5%) |
| Dec 2009 | $9.31 B(+113.1%) | $9.31 B(-57.3%) |
| Sep 2009 | - | $21.82 B(+75.1%) |
| Jun 2009 | - | $12.46 B(+107.0%) |
| Mar 2009 | - | $6.02 B(+37.7%) |
| Dec 2008 | $4.37 B(-18.1%) | $4.37 B(-23.6%) |
| Sep 2008 | - | $5.72 B(-22.1%) |
| Jun 2008 | - | $7.35 B(+16.8%) |
| Mar 2008 | - | $6.29 B(+17.9%) |
| Dec 2007 | $5.34 B(-9.8%) | $5.34 B(+2.5%) |
| Sep 2007 | - | $5.21 B(+50.1%) |
| Jun 2007 | - | $3.47 B(+65.1%) |
| Mar 2007 | - | $2.10 B(-64.5%) |
| Dec 2006 | $5.91 B | $5.91 B(-4.9%) |
| Sep 2006 | - | $6.22 B(-24.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2006 | - | $8.21 B(-19.4%) |
| Mar 2006 | - | $10.19 B(+6.3%) |
| Dec 2005 | $9.59 B(+233.0%) | $9.59 B(+228.5%) |
| Sep 2005 | - | $2.92 B(+52.2%) |
| Jun 2005 | - | $1.92 B(-19.8%) |
| Mar 2005 | - | $2.39 B(-17.0%) |
| Dec 2004 | $2.88 B(+139.7%) | $2.88 B(+7.9%) |
| Sep 2004 | - | $2.67 B(+66.7%) |
| Jun 2004 | - | $1.60 B(-9.2%) |
| Mar 2004 | - | $1.76 B(+46.7%) |
| Dec 2003 | $1.20 B(-46.5%) | $1.20 B(-44.8%) |
| Sep 2003 | - | $2.17 B(+30.6%) |
| Jun 2003 | - | $1.66 B(-24.9%) |
| Mar 2003 | - | $2.22 B(-1.2%) |
| Dec 2002 | $2.24 B(+4.6%) | $2.24 B(+49.9%) |
| Sep 2002 | - | $1.50 B(+13.5%) |
| Jun 2002 | - | $1.32 B(-55.2%) |
| Mar 2002 | - | $2.94 B(+37.3%) |
| Dec 2001 | $2.14 B(-15.5%) | $2.14 B(+31.2%) |
| Sep 2001 | - | $1.63 B(-22.5%) |
| Jun 2001 | - | $2.11 B(-2.3%) |
| Mar 2001 | - | $2.16 B(-14.9%) |
| Dec 2000 | $2.54 B(+25.5%) | $2.54 B(+65.3%) |
| Sep 2000 | - | $1.54 B(-45.3%) |
| Jun 2000 | - | $2.81 B(+26.2%) |
| Mar 2000 | - | $2.22 B(+9.9%) |
| Dec 1999 | $2.02 B(-22.4%) | $2.02 B(-3.9%) |
| Sep 1999 | - | $2.10 B(-7.3%) |
| Jun 1999 | - | $2.27 B(+26.5%) |
| Mar 1999 | - | $1.79 B(-31.2%) |
| Dec 1998 | $2.61 B(+131.6%) | $2.61 B(+7.3%) |
| Sep 1998 | - | $2.43 B(+70.5%) |
| Jun 1998 | - | $1.42 B(-10.8%) |
| Mar 1998 | - | $1.60 B(+41.9%) |
| Dec 1997 | $1.13 B(-16.8%) | $1.13 B(-12.2%) |
| Sep 1997 | - | $1.28 B(-19.2%) |
| Jun 1997 | - | $1.59 B(-8.6%) |
| Mar 1997 | - | $1.74 B(+28.4%) |
| Dec 1996 | $1.35 B(-26.8%) | $1.35 B(+0.6%) |
| Sep 1996 | - | $1.34 B(-20.3%) |
| Jun 1996 | - | $1.69 B(-3.8%) |
| Mar 1996 | - | $1.75 B(-5.1%) |
| Dec 1995 | $1.85 B(+15.2%) | $1.85 B(-3.1%) |
| Sep 1995 | - | $1.91 B(+14.5%) |
| Jun 1995 | - | $1.66 B(-25.1%) |
| Mar 1995 | - | $2.22 B(+38.5%) |
| Dec 1994 | $1.60 B(+93.4%) | $1.60 B(+32.2%) |
| Sep 1994 | - | $1.21 B(-0.5%) |
| Jun 1994 | - | $1.22 B(+33.0%) |
| Mar 1994 | - | $917.00 M(+10.6%) |
| Dec 1993 | $829.40 M(+44.2%) | $829.40 M(-30.7%) |
| Sep 1993 | - | $1.20 B(+41.2%) |
| Jun 1993 | - | $847.80 M(+20.7%) |
| Mar 1993 | - | $702.50 M(+22.2%) |
| Dec 1992 | $575.10 M(-27.9%) | $575.10 M(-33.8%) |
| Sep 1992 | - | $868.80 M(+21.4%) |
| Jun 1992 | - | $715.90 M(+3.0%) |
| Mar 1992 | - | $694.80 M(-12.9%) |
| Dec 1991 | $797.90 M(-1.1%) | $797.90 M(-13.3%) |
| Sep 1991 | - | $920.30 M(+28.1%) |
| Jun 1991 | - | $718.20 M(-7.8%) |
| Mar 1991 | - | $779.20 M(-3.4%) |
| Dec 1990 | $806.40 M(+17.7%) | $806.40 M(+24.5%) |
| Sep 1990 | - | $647.60 M(+15.5%) |
| Jun 1990 | - | $560.80 M(+10.2%) |
| Mar 1990 | - | $508.70 M(-25.7%) |
| Dec 1989 | $685.10 M(-55.8%) | $685.10 M(+9.8%) |
| Sep 1989 | - | $623.80 M(-59.8%) |
| Dec 1988 | $1.55 B(+35.0%) | $1.55 B(+35.0%) |
| Dec 1987 | $1.15 B(+18.9%) | $1.15 B(+18.9%) |
| Dec 1986 | $965.80 M(+14.7%) | $965.80 M(+14.7%) |
| Dec 1985 | $842.00 M(+13.1%) | $842.00 M(+13.1%) |
| Dec 1984 | $744.30 M | $744.30 M |
FAQ
- What is the all time high annual cash & cash equivalents for Merck & Co?
- What is the all time high quarterly cash and cash equivalents for Merck & Co?
What is the all time high annual cash & cash equivalents for Merck & Co?
Merck & Co all-time high annual cash & cash equivalents is $15.62 B
What is the all time high quarterly cash and cash equivalents for Merck & Co?
Merck & Co all-time high quarterly cash and cash equivalents is $21.82 B